Executive Director, MSAT – Type 1 Diabetes

About this role

Job Description General Summary: At Vertex, we’re driven by a shared purpose: to transform the lives of patients with serious diseases. The Executive Director, MSAT will provide strategic and hands-on leadership for Manufacturing Science & Technology (MSAT) across our Type 1 Diabetes cell therapy manufacturing network. This role is accountable for process performance, technical transfer, validation, continued process verification, comparability, and lifecycle management —with a particular focus on external manufacturing partners (CMOs) .

You will build and lead a high-performing MSAT organization that bridges Process Development and GMP Manufacturing, ensuring processes are robust, scalable, compliant, and inspection-ready from early clinical supply through commercialization. This is a highly cross-functional leadership position partnering with Technical Operations, Quality, CMC, Regulatory, Supply Chain, and external manufacturing partners.

Key Duties and Responsibilities:

MSAT Strategy & Network Leadership • Define and execute the MSAT strategy for T1D cell therapy manufacturing across a global external network , ensuring technical readiness for clinical development and commercial launch. • Establish and lead governance models for MSAT engagement with CMOs and co-invested sites, including joint technical forums, escalation pathways, and performance metrics. • Set technical standards and harmonized approaches across sites for process control, process validation, deviation management, and lifecycle improvements .

Tech Transfer & Manufacturing Readiness • Partner with Process Development to ensure right-first-time technology transfer into external manufacturing sites, ensuring operationalization of process knowledge, documentation readiness, and training for GMP execution. • Drive integrated readiness plans for pivotal trials and commercial launch: facility fit, equipment strategy, material qualification, batch records, and manufacturing execution (paper/eBR/MES). • Ensure robust site onboarding and sustained technical engagement—acting as the technical lead for process execution performance.

Process Characterization, Control Strategy & Validation • Own and evolve the control strategy in partnership with CMC, Quality, and Regulatory, ensuring scientifically sound and phase-appropriate controls. • Lead process validation/PPQ strategies, including sampling plans, acceptance criteria, statistical approaches, and continued verification. • Ensure alignment of critical process parameters (CPPs), critical quality attributes (CQAs), and in-process controls across sites.

Continued Process Verification (CPV), Trending & Operational Excellence • Build a best-in-class CPV and trending program across the network: yield, purity, potency, viability, cycle time, deviations, and release performance. • Lead investigations and technical risk assessments for major deviations, OOS/OOT, and atypical events—ensuring timely root cause, effective CAPAs, and sustained improvements. • Drive continuous improvement through process optimization, standardization, and lean problem solving, while maintaining compliance.

Change Control, Comparability & Lifecycle Management • Lead technical assessment and execution of change control across external sites (process, analytical, equipment, raw materials, suppliers). • Own comparability strategies for process changes and site transfers, ensuring robust data packages for regulatory submissions and inspection readiness. • Partner with Regulatory CMC to support IND/BLA/MAA content, HA questions, and commitments related to process and control strategy.

Materials, Raw Materials & Supplier Technical Oversight • Provide MSAT leadership for material qualification , supplier changes, and risk management (critical raw materials, reagents, single-use systems). • Partner with Supply Chain and Quality to ensure technical oversight for supplier network robustness, including dual sourcing strategies where appropriate.

Digital, Automation & Data Systems Enablement • Champion digital enablement of manufacturing—MES/eBR, historian integration, data pipelines, and analytics to improve right-first-time execution. • Promote automation and closed-system solutions where feasible to enhance robustness, reduce variability, and improve scalability.

People Leadership & Vertex Culture • Build, mentor, and lead a high-impact MSAT organization across disciplines (process engineers, tech transfer leads, validation engineers, data/trending experts). • Foster a culture of scientific rigor, transparency, collaboration, and urgency for patients —balancing speed with quality and compliance.

Knowledge and Skills: Technical Expertise • Deep understanding of GMP expectations for advanced therapies and late-stage readiness (validation, CPV, inspection readiness). • Proven capability in control strategy development, process characterization, and lifecycle management. • Strong experience with deviations/investigations, change control, and comparability strategies across multi-site networks. • Working knowledge of analytics strategy interface (method readiness, tech transfer, comparability support) and how it ties to product control.

Leadership & Influence • Demonstrated ability to lead through influence in complex, matrixed organizations and across external partner boundaries. • Strong executive communication skills with the ability to simplify complexity, drive alignment, and make risk-based decisions. • Track record of building high-performing teams and developing technical talent.

Education and Experience: • Advanced degree (MS/PhD preferred) in Chemical Engineering, Biomedical Engineering, Biotechnology, Life Sciences, or related discipline. • 15+ years of biopharmaceutical experience with progressive leadership in MSAT/Manufacturing/Process Engineering roles. • Significant experience in cell therapy and/or advanced biologics manufacturing ; experience supporting both clinical and commercial programs

Similar jobs

• Associate Medical Director/Medical Director, Endocrinology and Metabolism — Corcepttherapeutics · Redwood City, California, United States
• Director, GLP-1 and Cardiometabolic Health Program Manager — Omadahealth · Remote
• Executive Director & Head Clinical Data Management — Annexonbioscience · San Francisco Bay Area
• Executive Director, Direct-to-Patient Platform — Merck · North Wales (Upper Gwynedd), Pennsylvania, United States | Rahway, New Jersey, United States
• Executive Director, Global Commercial Leader, Cardiometabolic — Merck · Rahway, New Jersey, United States | North Wales (Upper Gwynedd), Pennsylvania, United States
• Executive Director, Global Medical Affairs Companion Diagnostic Lead — BeiGene · Remote
• Executive Director, Clinical Development, Breast Cancer — BeiGene · Remote
• Assoc Clinical Development Director (MD) — Gilead Sciences · Foster City, California, United States